What We're Reading: Page 212
Industry reads hand-picked by our editors
Jan 02, 2020
-
The New York Times
As Tens of Thousands Died, F.D.A. Failed to Police Opioids
-
MIT Technology Review
He Jiankui faces three years in prison for CRISPR babies
-
Reuters
Study finds Google system could improve breast cancer detection
Dec 23, 2019
-
ProPublica
Doctors Prescribe More of a Drug If They Receive Money from a Pharma Company Tied to It
-
Bloomberg
Year’s Best U.S. IPO Is a Little-Known Biotech With 420% Surge
-
The Wall Street Journal
A Genetic Test Led Seven Women in One Family to Have Major Surgery. Then the Odds Changed.
-
Endpoints News
Eisai scores an FDA approval for a homegrown sleep drug
Dec 20, 2019
-
The Wall Street Journal
Novartis to Offer World’s Most Expensive Drug for Free Via Lottery
-
STAT
Waning treatment is a warning for all 'one-and-done' therapies
-
S&P Global
Lawmakers seek to loosen US FDA drug approval requirements to allow early access
-
C&EN
An oral form of a blockbuster diabetes drug has arrived. Will people be able to get it?
Dec 19, 2019
Dec 18, 2019
Dec 17, 2019
-
The Wall Street Journal
ALS Drug Works in Study, Researchers Say
-
The New York Times
Purdue Pharma Payments to Sackler Family Soared Amid Opioid Crisis
-
POLITICO
Democrats box in Republicans on drug pricing
-
Endpoints News
Inside Astellas' $3B Audentes gene therapy acquisition: coded messages, a bidding war and $77M for the CEO
Previous
